Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Back to work

Supporting individuals when they return to work after an extended absence

- PMLiVE

AstraZeneca/Daiichi Sankyo’s Enhertu granted FDA approval in breast cancer

More than 300,000 cases of breast cancer are diagnosed in the US every year

- PMLiVE

Roche/Sarepta announce two-year results for Duchenne muscular dystrophy gene therapy

The muscle-wasting disorder is estimated to affect one in every 5,000 male births worldwide

- PMLiVE

BMS presents promising data for immunotherapy combination in phase 3 colorectal cancer trial

Over 154,000 cases of colorectal cancer are expected to be diagnosed in the US in 2025

- PMLiVE

The silent treatment – researching gene silencing for Alzheimer’s, Parkinson’s and motor neurone disease

The science behind gene-silencing technology and the barriers and challenges faced by drug developers

- PMLiVE

What does HEOR really mean in 2025?

Global healthcare systems are under unprecedented strain. As life expectancies rise and populations age, the proportion of people aged 60+ years is expected to soar. This both signals remarkable progress...

Petauri Evidence

- PMLiVE

Meet the Petauri experts at World EPA Congress

We are delighted to announce that market access and HEOR experts from Mtech Access - Powered by Petauri will be attending World Evidence, Pricing and Access Congress in Amsterdam on...

Petauri Evidence

Biogen Idec building

Biogen/Eisai’s Alzheimer’s drug approved by FDA for monthly maintenance dosing

The neurodegenerative disease affects almost seven million people in the US

- PMLiVE

Pfizer shares positive late-stage results for Braftovi regimen in colorectal cancer

The combination was approved in the US last month to treat BRAF V600E-mutant disease

- PMLiVE

Havas Health Network launches Havas Life London

The agency will offer brand, corporate and cause-related communications in global health and rare diseases

- PMLiVE

Promiscuous strategists

Good strategists are good for other things too

- PMLiVE

How to make your Medical Education sync with your marketing by EatMoreFruit’s Bethany Lowes Bush

Medical education faces challenges. Time is scarce. Resources are tight. Information overload is real. But by delivering genuine value through innovative formats that respect how HCPs actually learn and consume...

EatMoreFruit

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links